Early History {#S1}
=============

O-GlcNAcylation was discovered in the early 1980s when bovine milk galactosyltransferase was used as an enzymatic probe of terminal *N*-acetylglucosamine moieties in cells of the murine immune system ([@B1]). Later studies established *O*-GlcNAc's surprising nucleocytoplasmic subcellular localization and distribution at a time when dogma stated that protein glycosylation only occurs within the secretory pathway or extracellular compartments ([@B2]). O-GlcNAcylation was shown to be highly abundant within the nucleus and particularly enriched at the nuclear envelope and on nuclear pore proteins ([@B3]--[@B5]). However, O-GlcNAcylation was also found to be abundant on cytoskeletal proteins of human erythrocytes, which lack a nucleus ([@B6]). Viruses were also found to contain O-GlcNAcylated proteins, which occur on proteins surrounding their nucleic acid cores, rather than on their capsids, where other forms of "classical" protein glycosylation are found ([@B7]). O-GlcNAcylation was subsequently found to be highly enriched on proteins associated with chromatin in *Drosophila* ([@B8]), and *O*-GlcNAc was shown to not only be a major modifier of transcription factors ([@B9]), but also a major modification of the C-terminal domain (CTD) of RNA polymerase II itself ([@B10]). Early studies in lymphocytes showed that cellular activation resulted in rapid changes, suggesting that *O*-GlcNAc cycled like phosphorylation and could be a regulatory modification ([@B11]), which was later confirmed by the sugar's rapid cycling on small heat shock proteins, shown by classical pulse-chase analyses ([@B12]). An assay for *O*-GlcNAc transferase (OGT), based upon tritiated UDP-GlcNAc as the donor and synthetic peptide acceptors, was developed and OGT activity was identified and characterized ([@B13]). OGT was subsequently purified to apparent homogeneity by brute-force biochemical approaches combined with nucleotide affinity chromatography ([@B14]). O-GlcNAcase was originally purified from rat spleen cytosol ([@B15]) and was found to be similar to hexosaminidase C ([@B16], [@B17]), which was known but had not been purified to homogeneity. Based upon polypeptide sequencing, in conjunction with PCR cloning, the *OGT* cDNA from rat ([@B18]), *C. elegans* and human ([@B19]) were cloned. OGT was found to be a very highly conserved protein with no homology to other known glycosyltransferases. OGT was also found to have two distinct domains, a catalytic domain and a protein--protein interaction domain consisting of over 11 tetratricopeptide (TPR) repeats separated by a linker region. Likewise, O-GlcNAcase was purified from bovine brain and the protein was sequenced by mass spectrometry, and used to clone the enzyme from a human library ([@B20]). The *OGA* gene was found to be identical to *MGEA5* a putative hyaluronidase associated with meningioma ([@B21]). Early studies identified *O*-GlcNAc on nuclear receptors, tau protein in the brain, intermediate filament proteins, nuclear oncogenes and tumor suppressors, and many other proteins with a wide-range of functions \[reviewed in Ref. ([@B22])\].

More Recent Findings {#S2}
====================

As the tools for the detection and analysis of O-GlcNAcylation improved, it became apparent that this post-translational modification is much more abundant than previously expected \[reviewed in Ref. ([@B23], [@B24])\]. In addition, it was soon realized that not only was the donor for O-GlcNAcylation, UDP-GlcNAc, a major node of metabolism, but also that *O*-GlcNAc has extensive interplay with protein phosphorylation \[reviewed in Ref. ([@B23])\]. Gene deletion studies have shown that both OGT and O-GlcNAcase are essential genes in mammals and plants ([@B25]--[@B27]).

Like phosphorylation and ubquitination, O-GlcNAcylation regulates many different cellular processes. O-GlcNAcylation is essential in the process of lymphocyte activation in both B- and T-lymphocytes ([@B28]). There are several examples where the glycan regulates protein:protein interactions \[e.g., Ref. ([@B29], [@B30])\]. Nutrients fine-tune circadian clocks via O-GlcNAcylation ([@B31]--[@B34]). *O*-GlcNAc modulates the activity of the proteasome ([@B35]--[@B39]), and also has interplay with ubquitination ([@B40], [@B41]). Recent studies indicate that O-GlcNAcylation is very important to neuronal and brain functions, including synaptic plasticity, synaptic vesicle trafficking, and axonal branching ([@B42]--[@B46]). O-GlcNAcylation also regulates growth hormone signaling in plants ([@B27]), protects cells from acute stresses ([@B47]), and modulates transition through the cell cycle ([@B48]). Even though O-GlcNAcylation has not yet been documented to occur in yeast, such as *Saccharomyces cerevisiae* or *Schizosaccharomyces pombe*, *O*-GlcNAc does occur in some of oldest known eukaryotes ([@B49]), including in some important human parasites ([@B50]--[@B52]). In certain bacteria, O-GlcNAcylation regulates flagellar motility ([@B53]), and in *Streptococcus pneumonia*, O-GlcNAcylation of an adhesion plays a role in infection and pathogenesis ([@B54]). However, the bacterial OGT involved in each case is quite different from the eukaryotic enzyme.

As a key nutrient sensor, O-GlcNAcylation is fundamentally important to the regulation of transcription at nearly all levels, including regulation of the functions of RNA polymerase II itself ([@B55], [@B56]), modulating the activities of nearly all transcription factors ([@B30]), regulating both histone and DNA methylation ([@B57]--[@B61]), crosstalking with other epigenetic modifications ([@B62]), and serving as an integral part of the histone code ([@B63]). Not only does O-GlcNAcylation have extensive crosstalk with protein phosphorylation at the protein site level but also the sugar modifies many kinases and regulates their activities or specificity ([@B64]--[@B69]).

Given the myriad functions associated with O-GlcNAcylation, it is not surprising that this nutrient sensor plays a fundamental role in the etiology of diabetes and glucose toxicity ([@B70]--[@B72]). O-GlcNAcylation is elevated in all cancers studied to date and appears to play a role in tumor cell progression ([@B24], [@B73], [@B74]), and in patient prognosis ([@B75]). Given O-GlcNAcylation's abundance and presence on hundreds of proteins in the brain, it is also a major mechanism contributing to neurodegeneration ([@B76]--[@B78]). After 30-years of research on O-GlcNAcylation, it is now not only more apparent than ever that this post-translation modification plays a central role in the nutrient regulation of cellular physiology but also it is clear that we have a long way to go to fully understand the importance of O-GlcNAcylation in most cellular and disease processes.

Future Directions {#S3}
=================

Many important questions remain with respect to O-GlcNAcylation. (1) How does *O*-GlcNAc cycling achieve substrate specificity with only two known genes in mammals, *OGT* and *OGA (MGEA5)*? Clearly, several different mechanisms are involved. *In vitro*, OGT has remarkable specificity for peptide subtrates, which appears to change with UDP-GlcNAc concentrations ([@B79]). Most importantly, both enzymes function as part of transient holoenzyme complexes, which number in the hundreds, are cell type specific and serve to target the enzymes to their specific substrates. A key question is how is the formation of these holoenzyme complexes regulated by nutrients and other signals? (2) How are kinases regulated by O-GlcNAcylation? Many kinases are dynamically O-GlcNAcylated, and thus far, those studied are regulated by the glycan. How does this observation alter our view of signaling and system biological studies of cellular physiology? (3) How does O-GlcNAcylation play a role in neuronal functions and in learning and memory? O-GlcNAcylation is incredibly abundant in the mammalian brain, and in neurons, particularly at the synapse and in dendritic spines ([@B42], [@B45], [@B80]). Elucidation of *O*-GlcNAc's roles in normal neuronal functions and in brain biology will become a huge area of future research. (4) What are the specific roles of O-GlcNAcylation in nutrient regulation of transcription? While it is now clear that O-GlcNAcylation is fundamentally important in nearly every aspect of transcription, we currently know almost nothing with respect to its protein-specific or site-specific roles on individual transcription regulatory proteins. This area will remain an enormous challenge for some time to come.

Finally, while the tools to study O-GlcNAcylation have advanced substantially in the last three decades, there remains an acute need to develop better methods and approaches that can be applied by biologists. These include: (1) The development of many site-specific *O*-GlcNAc antibodies; (2) A molecular biology approach to either mimic O-GlcNAcylation or to generate site-specific O-GlcNAcylation on proteins; (3) Methods are need that can raise or lower O-GlcNAcylation on individual proteins or at individual sites to evaluate functions. Unfortunately, current methods either based upon inhibitors or genetic approaches to alter O-GlcNAcylation, all act globally. (5) There continues to be a need for better methods to both detect and site-map *O*-GlcNAc on proteins. The challenges in this field are large but so is the pay off for our understanding of cellular physiology and chronic disease.
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